Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Laboratory Facility Manager
International AIDS Vaccine Initiative - New York, NY
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Scientist/Sr. Scientist, Bio-analytical Chemistry
Dicerna Pharmaceuticals, Inc. - Watertown, MA
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Just Released: New Trends in Preventive and Therapeutic Vaccine
Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston

More Events >>

Duke University News

Most Popular Duke University Story

Duke researchers to test mosaic HIV vax candidate

October 20, 2010 — 1:43pm ET | By Liz Jones Hollis

Duke University researchers are assembling an international team to design the first human trial of a mosaic HIV vaccine candidate. Unlike traditional HIV vaccines that are designed to stimulate the Read more...

Duke University Press Releases

Saladax Biomedical, Inc. Announces Appointment of Gregory C. Critchfield, M.D., M.S. as Chairman of the Company's Board of Direc
$20 Million Endowment For Biomedical Engineering Research
Genetic sequencing alone doesn't offer a true picture of human disease
Millennium Research Group Analyst Available to Comment on a Recent Study’s Findings of Unnecessary Implantation of Defibri
Duke Accepts Potti Resignation; Retraction Process Initiated with Nature Medicine

Latest Headlines

HIV envelope protein approach elicits vaccine immune response
September 8, 2011
Duke researchers to test mosaic HIV vax candidate
October 20, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK